Apomorphine (Movapo, APO-go)

Non-ergot dopamine agonist (antiparkinsonian rescue agent)

Apomorphine (Movapo, APO-go)

Forms and strengths
Form: TabletStrength: 10 mg/mL
Print

Indication

  • Acute, intermittent treatment of hypomobility "off" episodes ("end-of-dose wearing off" and unpredictable "on/off" episodes) in advanced Parkinson disease that have not been adequately controlled by adjusting other Parkinson medications.
  • Studied only as an intermittent subcutaneous injection given as an adjunct to existing oral or transdermal Parkinson therapy, not as monotherapy.
  • Must never be given intravenously -- this is not an alternate route, it is a distinct and dangerous error (see Serious side effects).

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.